Global Ventriculoperitoneal (VP) Shunt System Market Growth 2026-2032
The global Ventriculoperitoneal (VP) Shunt System market size is predicted to grow from US$ 457 million in 2025 to US$ 740 million in 2032; it is expected to grow at a CAGR of 7.3% from 2026 to 2032.
A ventriculoperitoneal (VP) shunt system is a medical device, a thin tube, used to drain excess cerebrospinal fluid (CSF) from the brain's ventricles into the abdominal cavity (peritoneal cavity). It is a treatment for hydrocephalus, a condition where there is a buildup of CSF that can increase pressure on the brain, causing a range of problems. The system consists of a ventricular catheter in the brain, a one-way valve, and a distal catheter that runs under the skin to the abdomen.
In 2024, the global production of ventriculoperitoneal shunt systems reached 172.2 k units, with an average selling price of US$2,549 per unit. A typical single-line production capacity is approximately 30,000-50,000 units, and the industry's gross profit margin is approximately 50%-70%. Cost structure: Raw materials account for approximately 55%, manufacturing costs account for approximately 35%, and labor costs account for approximately 10%. Supply chain: Upstream includes medical-grade silicone, polyurethane, and sensors; downstream includes distributors, hospital procurement, and final clinical use.
United States market for Ventriculoperitoneal (VP) Shunt System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Ventriculoperitoneal (VP) Shunt System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Ventriculoperitoneal (VP) Shunt System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Ventriculoperitoneal (VP) Shunt System players cover Medtronic, Integra LifeSciences, MIETHKE MedTech, SOPHYSA, Hpbio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
This Insight Report provides a comprehensive analysis of the global Ventriculoperitoneal (VP) Shunt System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ventriculoperitoneal (VP) Shunt System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ventriculoperitoneal (VP) Shunt System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ventriculoperitoneal (VP) Shunt System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ventriculoperitoneal (VP) Shunt System.
This report presents a comprehensive overview, market shares, and growth opportunities of Ventriculoperitoneal (VP) Shunt System market by product type, application, key manufacturers and key regions and countries.
A ventriculoperitoneal (VP) shunt system is a medical device, a thin tube, used to drain excess cerebrospinal fluid (CSF) from the brain's ventricles into the abdominal cavity (peritoneal cavity). It is a treatment for hydrocephalus, a condition where there is a buildup of CSF that can increase pressure on the brain, causing a range of problems. The system consists of a ventricular catheter in the brain, a one-way valve, and a distal catheter that runs under the skin to the abdomen.
In 2024, the global production of ventriculoperitoneal shunt systems reached 172.2 k units, with an average selling price of US$2,549 per unit. A typical single-line production capacity is approximately 30,000-50,000 units, and the industry's gross profit margin is approximately 50%-70%. Cost structure: Raw materials account for approximately 55%, manufacturing costs account for approximately 35%, and labor costs account for approximately 10%. Supply chain: Upstream includes medical-grade silicone, polyurethane, and sensors; downstream includes distributors, hospital procurement, and final clinical use.
United States market for Ventriculoperitoneal (VP) Shunt System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Ventriculoperitoneal (VP) Shunt System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Ventriculoperitoneal (VP) Shunt System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Ventriculoperitoneal (VP) Shunt System players cover Medtronic, Integra LifeSciences, MIETHKE MedTech, SOPHYSA, Hpbio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Ventriculoperitoneal (VP) Shunt System Industry Forecast” looks at past sales and reviews total world Ventriculoperitoneal (VP) Shunt System sales in 2025, providing a comprehensive analysis by region and market sector of projected Ventriculoperitoneal (VP) Shunt System sales for 2026 through 2032. With Ventriculoperitoneal (VP) Shunt System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ventriculoperitoneal (VP) Shunt System industry.This Insight Report provides a comprehensive analysis of the global Ventriculoperitoneal (VP) Shunt System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ventriculoperitoneal (VP) Shunt System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ventriculoperitoneal (VP) Shunt System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ventriculoperitoneal (VP) Shunt System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ventriculoperitoneal (VP) Shunt System.
This report presents a comprehensive overview, market shares, and growth opportunities of Ventriculoperitoneal (VP) Shunt System market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Adjustable Valve
- Monopressure Valve
Segmentation by Structure:
- One-piece
- Two-piece
- Other
Segmentation by Application:
- Adults
- Children and Newborns
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medtronic
- Integra LifeSciences
- MIETHKE MedTech
- SOPHYSA
- Hpbio
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Ventriculoperitoneal (VP) Shunt System market?
- What factors are driving Ventriculoperitoneal (VP) Shunt System market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Ventriculoperitoneal (VP) Shunt System market opportunities vary by end market size?
- How does Ventriculoperitoneal (VP) Shunt System break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ventriculoperitoneal (VP) Shunt System Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Ventriculoperitoneal (VP) Shunt System by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Ventriculoperitoneal (VP) Shunt System by Country/Region, 2021, 2025 & 2032
2.2 Ventriculoperitoneal (VP) Shunt System Segment by Type
2.2.1 Adjustable Valve
2.2.2 Monopressure Valve
2.2.3 Ventriculoperitoneal (VP) Shunt System Sales by Type
2.2.3.1 Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Type (2021-2026)
2.2.3.2 Global Ventriculoperitoneal (VP) Shunt System Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Ventriculoperitoneal (VP) Shunt System Sale Price by Type (2021-2026)
2.3 Ventriculoperitoneal (VP) Shunt System Segment by Structure
2.3.1 One-piece
2.3.2 Two-piece
2.3.3 Other
2.3.4 Ventriculoperitoneal (VP) Shunt System Sales by Structure
2.3.4.1 Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Structure (2021-2026)
2.3.4.2 Global Ventriculoperitoneal (VP) Shunt System Revenue and Market Share by Structure (2021-2026)
2.3.4.3 Global Ventriculoperitoneal (VP) Shunt System Sale Price by Structure (2021-2026)
2.4 Ventriculoperitoneal (VP) Shunt System Segment by Application
2.4.1 Adults
2.4.2 Children and Newborns
2.4.3 Ventriculoperitoneal (VP) Shunt System Sales by Application
2.4.3.1 Global Ventriculoperitoneal (VP) Shunt System Sale Market Share by Application (2021-2026)
2.4.3.2 Global Ventriculoperitoneal (VP) Shunt System Revenue and Market Share by Application (2021-2026)
2.4.3.3 Global Ventriculoperitoneal (VP) Shunt System Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Ventriculoperitoneal (VP) Shunt System Breakdown Data by Company
3.1.1 Global Ventriculoperitoneal (VP) Shunt System Annual Sales by Company (2021-2026)
3.1.2 Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Company (2021-2026)
3.2 Global Ventriculoperitoneal (VP) Shunt System Annual Revenue by Company (2021-2026)
3.2.1 Global Ventriculoperitoneal (VP) Shunt System Revenue by Company (2021-2026)
3.2.2 Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Company (2021-2026)
3.3 Global Ventriculoperitoneal (VP) Shunt System Sale Price by Company
3.4 Key Manufacturers Ventriculoperitoneal (VP) Shunt System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ventriculoperitoneal (VP) Shunt System Product Location Distribution
3.4.2 Players Ventriculoperitoneal (VP) Shunt System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VENTRICULOPERITONEAL (VP) SHUNT SYSTEM BY GEOGRAPHIC REGION
4.1 World Historic Ventriculoperitoneal (VP) Shunt System Market Size by Geographic Region (2021-2026)
4.1.1 Global Ventriculoperitoneal (VP) Shunt System Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Ventriculoperitoneal (VP) Shunt System Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Ventriculoperitoneal (VP) Shunt System Market Size by Country/Region (2021-2026)
4.2.1 Global Ventriculoperitoneal (VP) Shunt System Annual Sales by Country/Region (2021-2026)
4.2.2 Global Ventriculoperitoneal (VP) Shunt System Annual Revenue by Country/Region (2021-2026)
4.3 Americas Ventriculoperitoneal (VP) Shunt System Sales Growth
4.4 APAC Ventriculoperitoneal (VP) Shunt System Sales Growth
4.5 Europe Ventriculoperitoneal (VP) Shunt System Sales Growth
4.6 Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales Growth
5 AMERICAS
5.1 Americas Ventriculoperitoneal (VP) Shunt System Sales by Country
5.1.1 Americas Ventriculoperitoneal (VP) Shunt System Sales by Country (2021-2026)
5.1.2 Americas Ventriculoperitoneal (VP) Shunt System Revenue by Country (2021-2026)
5.2 Americas Ventriculoperitoneal (VP) Shunt System Sales by Type (2021-2026)
5.3 Americas Ventriculoperitoneal (VP) Shunt System Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ventriculoperitoneal (VP) Shunt System Sales by Region
6.1.1 APAC Ventriculoperitoneal (VP) Shunt System Sales by Region (2021-2026)
6.1.2 APAC Ventriculoperitoneal (VP) Shunt System Revenue by Region (2021-2026)
6.2 APAC Ventriculoperitoneal (VP) Shunt System Sales by Type (2021-2026)
6.3 APAC Ventriculoperitoneal (VP) Shunt System Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Ventriculoperitoneal (VP) Shunt System by Country
7.1.1 Europe Ventriculoperitoneal (VP) Shunt System Sales by Country (2021-2026)
7.1.2 Europe Ventriculoperitoneal (VP) Shunt System Revenue by Country (2021-2026)
7.2 Europe Ventriculoperitoneal (VP) Shunt System Sales by Type (2021-2026)
7.3 Europe Ventriculoperitoneal (VP) Shunt System Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ventriculoperitoneal (VP) Shunt System by Country
8.1.1 Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales by Country (2021-2026)
8.1.2 Middle East & Africa Ventriculoperitoneal (VP) Shunt System Revenue by Country (2021-2026)
8.2 Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales by Type (2021-2026)
8.3 Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ventriculoperitoneal (VP) Shunt System
10.3 Manufacturing Process Analysis of Ventriculoperitoneal (VP) Shunt System
10.4 Industry Chain Structure of Ventriculoperitoneal (VP) Shunt System
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ventriculoperitoneal (VP) Shunt System Distributors
11.3 Ventriculoperitoneal (VP) Shunt System Customer
12 WORLD FORECAST REVIEW FOR VENTRICULOPERITONEAL (VP) SHUNT SYSTEM BY GEOGRAPHIC REGION
12.1 Global Ventriculoperitoneal (VP) Shunt System Market Size Forecast by Region
12.1.1 Global Ventriculoperitoneal (VP) Shunt System Forecast by Region (2027-2032)
12.1.2 Global Ventriculoperitoneal (VP) Shunt System Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Ventriculoperitoneal (VP) Shunt System Forecast by Type (2027-2032)
12.7 Global Ventriculoperitoneal (VP) Shunt System Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Ventriculoperitoneal (VP) Shunt System Product Portfolios and Specifications
13.1.3 Medtronic Ventriculoperitoneal (VP) Shunt System Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Integra LifeSciences
13.2.1 Integra LifeSciences Company Information
13.2.2 Integra LifeSciences Ventriculoperitoneal (VP) Shunt System Product Portfolios and Specifications
13.2.3 Integra LifeSciences Ventriculoperitoneal (VP) Shunt System Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Integra LifeSciences Main Business Overview
13.2.5 Integra LifeSciences Latest Developments
13.3 MIETHKE MedTech
13.3.1 MIETHKE MedTech Company Information
13.3.2 MIETHKE MedTech Ventriculoperitoneal (VP) Shunt System Product Portfolios and Specifications
13.3.3 MIETHKE MedTech Ventriculoperitoneal (VP) Shunt System Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 MIETHKE MedTech Main Business Overview
13.3.5 MIETHKE MedTech Latest Developments
13.4 SOPHYSA
13.4.1 SOPHYSA Company Information
13.4.2 SOPHYSA Ventriculoperitoneal (VP) Shunt System Product Portfolios and Specifications
13.4.3 SOPHYSA Ventriculoperitoneal (VP) Shunt System Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 SOPHYSA Main Business Overview
13.4.5 SOPHYSA Latest Developments
13.5 Hpbio
13.5.1 Hpbio Company Information
13.5.2 Hpbio Ventriculoperitoneal (VP) Shunt System Product Portfolios and Specifications
13.5.3 Hpbio Ventriculoperitoneal (VP) Shunt System Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Hpbio Main Business Overview
13.5.5 Hpbio Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ventriculoperitoneal (VP) Shunt System Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Ventriculoperitoneal (VP) Shunt System by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Ventriculoperitoneal (VP) Shunt System by Country/Region, 2021, 2025 & 2032
2.2 Ventriculoperitoneal (VP) Shunt System Segment by Type
2.2.1 Adjustable Valve
2.2.2 Monopressure Valve
2.2.3 Ventriculoperitoneal (VP) Shunt System Sales by Type
2.2.3.1 Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Type (2021-2026)
2.2.3.2 Global Ventriculoperitoneal (VP) Shunt System Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Ventriculoperitoneal (VP) Shunt System Sale Price by Type (2021-2026)
2.3 Ventriculoperitoneal (VP) Shunt System Segment by Structure
2.3.1 One-piece
2.3.2 Two-piece
2.3.3 Other
2.3.4 Ventriculoperitoneal (VP) Shunt System Sales by Structure
2.3.4.1 Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Structure (2021-2026)
2.3.4.2 Global Ventriculoperitoneal (VP) Shunt System Revenue and Market Share by Structure (2021-2026)
2.3.4.3 Global Ventriculoperitoneal (VP) Shunt System Sale Price by Structure (2021-2026)
2.4 Ventriculoperitoneal (VP) Shunt System Segment by Application
2.4.1 Adults
2.4.2 Children and Newborns
2.4.3 Ventriculoperitoneal (VP) Shunt System Sales by Application
2.4.3.1 Global Ventriculoperitoneal (VP) Shunt System Sale Market Share by Application (2021-2026)
2.4.3.2 Global Ventriculoperitoneal (VP) Shunt System Revenue and Market Share by Application (2021-2026)
2.4.3.3 Global Ventriculoperitoneal (VP) Shunt System Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Ventriculoperitoneal (VP) Shunt System Breakdown Data by Company
3.1.1 Global Ventriculoperitoneal (VP) Shunt System Annual Sales by Company (2021-2026)
3.1.2 Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Company (2021-2026)
3.2 Global Ventriculoperitoneal (VP) Shunt System Annual Revenue by Company (2021-2026)
3.2.1 Global Ventriculoperitoneal (VP) Shunt System Revenue by Company (2021-2026)
3.2.2 Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Company (2021-2026)
3.3 Global Ventriculoperitoneal (VP) Shunt System Sale Price by Company
3.4 Key Manufacturers Ventriculoperitoneal (VP) Shunt System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ventriculoperitoneal (VP) Shunt System Product Location Distribution
3.4.2 Players Ventriculoperitoneal (VP) Shunt System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VENTRICULOPERITONEAL (VP) SHUNT SYSTEM BY GEOGRAPHIC REGION
4.1 World Historic Ventriculoperitoneal (VP) Shunt System Market Size by Geographic Region (2021-2026)
4.1.1 Global Ventriculoperitoneal (VP) Shunt System Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Ventriculoperitoneal (VP) Shunt System Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Ventriculoperitoneal (VP) Shunt System Market Size by Country/Region (2021-2026)
4.2.1 Global Ventriculoperitoneal (VP) Shunt System Annual Sales by Country/Region (2021-2026)
4.2.2 Global Ventriculoperitoneal (VP) Shunt System Annual Revenue by Country/Region (2021-2026)
4.3 Americas Ventriculoperitoneal (VP) Shunt System Sales Growth
4.4 APAC Ventriculoperitoneal (VP) Shunt System Sales Growth
4.5 Europe Ventriculoperitoneal (VP) Shunt System Sales Growth
4.6 Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales Growth
5 AMERICAS
5.1 Americas Ventriculoperitoneal (VP) Shunt System Sales by Country
5.1.1 Americas Ventriculoperitoneal (VP) Shunt System Sales by Country (2021-2026)
5.1.2 Americas Ventriculoperitoneal (VP) Shunt System Revenue by Country (2021-2026)
5.2 Americas Ventriculoperitoneal (VP) Shunt System Sales by Type (2021-2026)
5.3 Americas Ventriculoperitoneal (VP) Shunt System Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ventriculoperitoneal (VP) Shunt System Sales by Region
6.1.1 APAC Ventriculoperitoneal (VP) Shunt System Sales by Region (2021-2026)
6.1.2 APAC Ventriculoperitoneal (VP) Shunt System Revenue by Region (2021-2026)
6.2 APAC Ventriculoperitoneal (VP) Shunt System Sales by Type (2021-2026)
6.3 APAC Ventriculoperitoneal (VP) Shunt System Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Ventriculoperitoneal (VP) Shunt System by Country
7.1.1 Europe Ventriculoperitoneal (VP) Shunt System Sales by Country (2021-2026)
7.1.2 Europe Ventriculoperitoneal (VP) Shunt System Revenue by Country (2021-2026)
7.2 Europe Ventriculoperitoneal (VP) Shunt System Sales by Type (2021-2026)
7.3 Europe Ventriculoperitoneal (VP) Shunt System Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ventriculoperitoneal (VP) Shunt System by Country
8.1.1 Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales by Country (2021-2026)
8.1.2 Middle East & Africa Ventriculoperitoneal (VP) Shunt System Revenue by Country (2021-2026)
8.2 Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales by Type (2021-2026)
8.3 Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ventriculoperitoneal (VP) Shunt System
10.3 Manufacturing Process Analysis of Ventriculoperitoneal (VP) Shunt System
10.4 Industry Chain Structure of Ventriculoperitoneal (VP) Shunt System
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ventriculoperitoneal (VP) Shunt System Distributors
11.3 Ventriculoperitoneal (VP) Shunt System Customer
12 WORLD FORECAST REVIEW FOR VENTRICULOPERITONEAL (VP) SHUNT SYSTEM BY GEOGRAPHIC REGION
12.1 Global Ventriculoperitoneal (VP) Shunt System Market Size Forecast by Region
12.1.1 Global Ventriculoperitoneal (VP) Shunt System Forecast by Region (2027-2032)
12.1.2 Global Ventriculoperitoneal (VP) Shunt System Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Ventriculoperitoneal (VP) Shunt System Forecast by Type (2027-2032)
12.7 Global Ventriculoperitoneal (VP) Shunt System Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Ventriculoperitoneal (VP) Shunt System Product Portfolios and Specifications
13.1.3 Medtronic Ventriculoperitoneal (VP) Shunt System Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Integra LifeSciences
13.2.1 Integra LifeSciences Company Information
13.2.2 Integra LifeSciences Ventriculoperitoneal (VP) Shunt System Product Portfolios and Specifications
13.2.3 Integra LifeSciences Ventriculoperitoneal (VP) Shunt System Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Integra LifeSciences Main Business Overview
13.2.5 Integra LifeSciences Latest Developments
13.3 MIETHKE MedTech
13.3.1 MIETHKE MedTech Company Information
13.3.2 MIETHKE MedTech Ventriculoperitoneal (VP) Shunt System Product Portfolios and Specifications
13.3.3 MIETHKE MedTech Ventriculoperitoneal (VP) Shunt System Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 MIETHKE MedTech Main Business Overview
13.3.5 MIETHKE MedTech Latest Developments
13.4 SOPHYSA
13.4.1 SOPHYSA Company Information
13.4.2 SOPHYSA Ventriculoperitoneal (VP) Shunt System Product Portfolios and Specifications
13.4.3 SOPHYSA Ventriculoperitoneal (VP) Shunt System Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 SOPHYSA Main Business Overview
13.4.5 SOPHYSA Latest Developments
13.5 Hpbio
13.5.1 Hpbio Company Information
13.5.2 Hpbio Ventriculoperitoneal (VP) Shunt System Product Portfolios and Specifications
13.5.3 Hpbio Ventriculoperitoneal (VP) Shunt System Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Hpbio Main Business Overview
13.5.5 Hpbio Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Ventriculoperitoneal (VP) Shunt System Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Ventriculoperitoneal (VP) Shunt System Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Adjustable Valve
Table 4. Major Players of Monopressure Valve
Table 5. Global Ventriculoperitoneal (VP) Shunt System Sales by Type (2021-2026) & (K Units)
Table 6. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Type (2021-2026)
Table 7. Global Ventriculoperitoneal (VP) Shunt System Revenue by Type (2021-2026) & ($ million)
Table 8. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Type (2021-2026)
Table 9. Global Ventriculoperitoneal (VP) Shunt System Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of One-piece
Table 11. Major Players of Two-piece
Table 12. Major Players of Other
Table 13. Global Ventriculoperitoneal (VP) Shunt System Sales by Structure (2021-2026) & (K Units)
Table 14. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Structure (2021-2026)
Table 15. Global Ventriculoperitoneal (VP) Shunt System Revenue by Structure (2021-2026) & ($ million)
Table 16. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Structure (2021-2026)
Table 17. Global Ventriculoperitoneal (VP) Shunt System Sale Price by Structure (2021-2026) & (US$/Unit)
Table 18. Global Ventriculoperitoneal (VP) Shunt System Sale by Application (2021-2026) & (K Units)
Table 19. Global Ventriculoperitoneal (VP) Shunt System Sale Market Share by Application (2021-2026)
Table 20. Global Ventriculoperitoneal (VP) Shunt System Revenue by Application (2021-2026) & ($ million)
Table 21. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Application (2021-2026)
Table 22. Global Ventriculoperitoneal (VP) Shunt System Sale Price by Application (2021-2026) & (US$/Unit)
Table 23. Global Ventriculoperitoneal (VP) Shunt System Sales by Company (2021-2026) & (K Units)
Table 24. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Company (2021-2026)
Table 25. Global Ventriculoperitoneal (VP) Shunt System Revenue by Company (2021-2026) & ($ millions)
Table 26. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Company (2021-2026)
Table 27. Global Ventriculoperitoneal (VP) Shunt System Sale Price by Company (2021-2026) & (US$/Unit)
Table 28. Key Manufacturers Ventriculoperitoneal (VP) Shunt System Producing Area Distribution and Sales Area
Table 29. Players Ventriculoperitoneal (VP) Shunt System Products Offered
Table 30. Ventriculoperitoneal (VP) Shunt System Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Market M&A Activity & Strategy
Table 33. Global Ventriculoperitoneal (VP) Shunt System Sales by Geographic Region (2021-2026) & (K Units)
Table 34. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share Geographic Region (2021-2026)
Table 35. Global Ventriculoperitoneal (VP) Shunt System Revenue by Geographic Region (2021-2026) & ($ millions)
Table 36. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Geographic Region (2021-2026)
Table 37. Global Ventriculoperitoneal (VP) Shunt System Sales by Country/Region (2021-2026) & (K Units)
Table 38. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Country/Region (2021-2026)
Table 39. Global Ventriculoperitoneal (VP) Shunt System Revenue by Country/Region (2021-2026) & ($ millions)
Table 40. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Country/Region (2021-2026)
Table 41. Americas Ventriculoperitoneal (VP) Shunt System Sales by Country (2021-2026) & (K Units)
Table 42. Americas Ventriculoperitoneal (VP) Shunt System Sales Market Share by Country (2021-2026)
Table 43. Americas Ventriculoperitoneal (VP) Shunt System Revenue by Country (2021-2026) & ($ millions)
Table 44. Americas Ventriculoperitoneal (VP) Shunt System Sales by Type (2021-2026) & (K Units)
Table 45. Americas Ventriculoperitoneal (VP) Shunt System Sales by Application (2021-2026) & (K Units)
Table 46. APAC Ventriculoperitoneal (VP) Shunt System Sales by Region (2021-2026) & (K Units)
Table 47. APAC Ventriculoperitoneal (VP) Shunt System Sales Market Share by Region (2021-2026)
Table 48. APAC Ventriculoperitoneal (VP) Shunt System Revenue by Region (2021-2026) & ($ millions)
Table 49. APAC Ventriculoperitoneal (VP) Shunt System Sales by Type (2021-2026) & (K Units)
Table 50. APAC Ventriculoperitoneal (VP) Shunt System Sales by Application (2021-2026) & (K Units)
Table 51. Europe Ventriculoperitoneal (VP) Shunt System Sales by Country (2021-2026) & (K Units)
Table 52. Europe Ventriculoperitoneal (VP) Shunt System Revenue by Country (2021-2026) & ($ millions)
Table 53. Europe Ventriculoperitoneal (VP) Shunt System Sales by Type (2021-2026) & (K Units)
Table 54. Europe Ventriculoperitoneal (VP) Shunt System Sales by Application (2021-2026) & (K Units)
Table 55. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales by Country (2021-2026) & (K Units)
Table 56. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Country (2021-2026)
Table 57. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales by Type (2021-2026) & (K Units)
Table 58. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales by Application (2021-2026) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Ventriculoperitoneal (VP) Shunt System
Table 60. Key Market Challenges & Risks of Ventriculoperitoneal (VP) Shunt System
Table 61. Key Industry Trends of Ventriculoperitoneal (VP) Shunt System
Table 62. Ventriculoperitoneal (VP) Shunt System Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Ventriculoperitoneal (VP) Shunt System Distributors List
Table 65. Ventriculoperitoneal (VP) Shunt System Customer List
Table 66. Global Ventriculoperitoneal (VP) Shunt System Sales Forecast by Region (2027-2032) & (K Units)
Table 67. Global Ventriculoperitoneal (VP) Shunt System Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Americas Ventriculoperitoneal (VP) Shunt System Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Americas Ventriculoperitoneal (VP) Shunt System Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. APAC Ventriculoperitoneal (VP) Shunt System Sales Forecast by Region (2027-2032) & (K Units)
Table 71. APAC Ventriculoperitoneal (VP) Shunt System Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 72. Europe Ventriculoperitoneal (VP) Shunt System Sales Forecast by Country (2027-2032) & (K Units)
Table 73. Europe Ventriculoperitoneal (VP) Shunt System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 74. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales Forecast by Country (2027-2032) & (K Units)
Table 75. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. Global Ventriculoperitoneal (VP) Shunt System Sales Forecast by Type (2027-2032) & (K Units)
Table 77. Global Ventriculoperitoneal (VP) Shunt System Revenue Forecast by Type (2027-2032) & ($ millions)
Table 78. Global Ventriculoperitoneal (VP) Shunt System Sales Forecast by Application (2027-2032) & (K Units)
Table 79. Global Ventriculoperitoneal (VP) Shunt System Revenue Forecast by Application (2027-2032) & ($ millions)
Table 80. Medtronic Basic Information, Ventriculoperitoneal (VP) Shunt System Manufacturing Base, Sales Area and Its Competitors
Table 81. Medtronic Ventriculoperitoneal (VP) Shunt System Product Portfolios and Specifications
Table 82. Medtronic Ventriculoperitoneal (VP) Shunt System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Medtronic Main Business
Table 84. Medtronic Latest Developments
Table 85. Integra LifeSciences Basic Information, Ventriculoperitoneal (VP) Shunt System Manufacturing Base, Sales Area and Its Competitors
Table 86. Integra LifeSciences Ventriculoperitoneal (VP) Shunt System Product Portfolios and Specifications
Table 87. Integra LifeSciences Ventriculoperitoneal (VP) Shunt System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Integra LifeSciences Main Business
Table 89. Integra LifeSciences Latest Developments
Table 90. MIETHKE MedTech Basic Information, Ventriculoperitoneal (VP) Shunt System Manufacturing Base, Sales Area and Its Competitors
Table 91. MIETHKE MedTech Ventriculoperitoneal (VP) Shunt System Product Portfolios and Specifications
Table 92. MIETHKE MedTech Ventriculoperitoneal (VP) Shunt System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. MIETHKE MedTech Main Business
Table 94. MIETHKE MedTech Latest Developments
Table 95. SOPHYSA Basic Information, Ventriculoperitoneal (VP) Shunt System Manufacturing Base, Sales Area and Its Competitors
Table 96. SOPHYSA Ventriculoperitoneal (VP) Shunt System Product Portfolios and Specifications
Table 97. SOPHYSA Ventriculoperitoneal (VP) Shunt System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. SOPHYSA Main Business
Table 99. SOPHYSA Latest Developments
Table 100. Hpbio Basic Information, Ventriculoperitoneal (VP) Shunt System Manufacturing Base, Sales Area and Its Competitors
Table 101. Hpbio Ventriculoperitoneal (VP) Shunt System Product Portfolios and Specifications
Table 102. Hpbio Ventriculoperitoneal (VP) Shunt System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Hpbio Main Business
Table 104. Hpbio Latest Developments
Table 1. Ventriculoperitoneal (VP) Shunt System Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Ventriculoperitoneal (VP) Shunt System Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Adjustable Valve
Table 4. Major Players of Monopressure Valve
Table 5. Global Ventriculoperitoneal (VP) Shunt System Sales by Type (2021-2026) & (K Units)
Table 6. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Type (2021-2026)
Table 7. Global Ventriculoperitoneal (VP) Shunt System Revenue by Type (2021-2026) & ($ million)
Table 8. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Type (2021-2026)
Table 9. Global Ventriculoperitoneal (VP) Shunt System Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of One-piece
Table 11. Major Players of Two-piece
Table 12. Major Players of Other
Table 13. Global Ventriculoperitoneal (VP) Shunt System Sales by Structure (2021-2026) & (K Units)
Table 14. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Structure (2021-2026)
Table 15. Global Ventriculoperitoneal (VP) Shunt System Revenue by Structure (2021-2026) & ($ million)
Table 16. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Structure (2021-2026)
Table 17. Global Ventriculoperitoneal (VP) Shunt System Sale Price by Structure (2021-2026) & (US$/Unit)
Table 18. Global Ventriculoperitoneal (VP) Shunt System Sale by Application (2021-2026) & (K Units)
Table 19. Global Ventriculoperitoneal (VP) Shunt System Sale Market Share by Application (2021-2026)
Table 20. Global Ventriculoperitoneal (VP) Shunt System Revenue by Application (2021-2026) & ($ million)
Table 21. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Application (2021-2026)
Table 22. Global Ventriculoperitoneal (VP) Shunt System Sale Price by Application (2021-2026) & (US$/Unit)
Table 23. Global Ventriculoperitoneal (VP) Shunt System Sales by Company (2021-2026) & (K Units)
Table 24. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Company (2021-2026)
Table 25. Global Ventriculoperitoneal (VP) Shunt System Revenue by Company (2021-2026) & ($ millions)
Table 26. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Company (2021-2026)
Table 27. Global Ventriculoperitoneal (VP) Shunt System Sale Price by Company (2021-2026) & (US$/Unit)
Table 28. Key Manufacturers Ventriculoperitoneal (VP) Shunt System Producing Area Distribution and Sales Area
Table 29. Players Ventriculoperitoneal (VP) Shunt System Products Offered
Table 30. Ventriculoperitoneal (VP) Shunt System Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Market M&A Activity & Strategy
Table 33. Global Ventriculoperitoneal (VP) Shunt System Sales by Geographic Region (2021-2026) & (K Units)
Table 34. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share Geographic Region (2021-2026)
Table 35. Global Ventriculoperitoneal (VP) Shunt System Revenue by Geographic Region (2021-2026) & ($ millions)
Table 36. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Geographic Region (2021-2026)
Table 37. Global Ventriculoperitoneal (VP) Shunt System Sales by Country/Region (2021-2026) & (K Units)
Table 38. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Country/Region (2021-2026)
Table 39. Global Ventriculoperitoneal (VP) Shunt System Revenue by Country/Region (2021-2026) & ($ millions)
Table 40. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Country/Region (2021-2026)
Table 41. Americas Ventriculoperitoneal (VP) Shunt System Sales by Country (2021-2026) & (K Units)
Table 42. Americas Ventriculoperitoneal (VP) Shunt System Sales Market Share by Country (2021-2026)
Table 43. Americas Ventriculoperitoneal (VP) Shunt System Revenue by Country (2021-2026) & ($ millions)
Table 44. Americas Ventriculoperitoneal (VP) Shunt System Sales by Type (2021-2026) & (K Units)
Table 45. Americas Ventriculoperitoneal (VP) Shunt System Sales by Application (2021-2026) & (K Units)
Table 46. APAC Ventriculoperitoneal (VP) Shunt System Sales by Region (2021-2026) & (K Units)
Table 47. APAC Ventriculoperitoneal (VP) Shunt System Sales Market Share by Region (2021-2026)
Table 48. APAC Ventriculoperitoneal (VP) Shunt System Revenue by Region (2021-2026) & ($ millions)
Table 49. APAC Ventriculoperitoneal (VP) Shunt System Sales by Type (2021-2026) & (K Units)
Table 50. APAC Ventriculoperitoneal (VP) Shunt System Sales by Application (2021-2026) & (K Units)
Table 51. Europe Ventriculoperitoneal (VP) Shunt System Sales by Country (2021-2026) & (K Units)
Table 52. Europe Ventriculoperitoneal (VP) Shunt System Revenue by Country (2021-2026) & ($ millions)
Table 53. Europe Ventriculoperitoneal (VP) Shunt System Sales by Type (2021-2026) & (K Units)
Table 54. Europe Ventriculoperitoneal (VP) Shunt System Sales by Application (2021-2026) & (K Units)
Table 55. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales by Country (2021-2026) & (K Units)
Table 56. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Country (2021-2026)
Table 57. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales by Type (2021-2026) & (K Units)
Table 58. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales by Application (2021-2026) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Ventriculoperitoneal (VP) Shunt System
Table 60. Key Market Challenges & Risks of Ventriculoperitoneal (VP) Shunt System
Table 61. Key Industry Trends of Ventriculoperitoneal (VP) Shunt System
Table 62. Ventriculoperitoneal (VP) Shunt System Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Ventriculoperitoneal (VP) Shunt System Distributors List
Table 65. Ventriculoperitoneal (VP) Shunt System Customer List
Table 66. Global Ventriculoperitoneal (VP) Shunt System Sales Forecast by Region (2027-2032) & (K Units)
Table 67. Global Ventriculoperitoneal (VP) Shunt System Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Americas Ventriculoperitoneal (VP) Shunt System Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Americas Ventriculoperitoneal (VP) Shunt System Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. APAC Ventriculoperitoneal (VP) Shunt System Sales Forecast by Region (2027-2032) & (K Units)
Table 71. APAC Ventriculoperitoneal (VP) Shunt System Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 72. Europe Ventriculoperitoneal (VP) Shunt System Sales Forecast by Country (2027-2032) & (K Units)
Table 73. Europe Ventriculoperitoneal (VP) Shunt System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 74. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales Forecast by Country (2027-2032) & (K Units)
Table 75. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. Global Ventriculoperitoneal (VP) Shunt System Sales Forecast by Type (2027-2032) & (K Units)
Table 77. Global Ventriculoperitoneal (VP) Shunt System Revenue Forecast by Type (2027-2032) & ($ millions)
Table 78. Global Ventriculoperitoneal (VP) Shunt System Sales Forecast by Application (2027-2032) & (K Units)
Table 79. Global Ventriculoperitoneal (VP) Shunt System Revenue Forecast by Application (2027-2032) & ($ millions)
Table 80. Medtronic Basic Information, Ventriculoperitoneal (VP) Shunt System Manufacturing Base, Sales Area and Its Competitors
Table 81. Medtronic Ventriculoperitoneal (VP) Shunt System Product Portfolios and Specifications
Table 82. Medtronic Ventriculoperitoneal (VP) Shunt System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Medtronic Main Business
Table 84. Medtronic Latest Developments
Table 85. Integra LifeSciences Basic Information, Ventriculoperitoneal (VP) Shunt System Manufacturing Base, Sales Area and Its Competitors
Table 86. Integra LifeSciences Ventriculoperitoneal (VP) Shunt System Product Portfolios and Specifications
Table 87. Integra LifeSciences Ventriculoperitoneal (VP) Shunt System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Integra LifeSciences Main Business
Table 89. Integra LifeSciences Latest Developments
Table 90. MIETHKE MedTech Basic Information, Ventriculoperitoneal (VP) Shunt System Manufacturing Base, Sales Area and Its Competitors
Table 91. MIETHKE MedTech Ventriculoperitoneal (VP) Shunt System Product Portfolios and Specifications
Table 92. MIETHKE MedTech Ventriculoperitoneal (VP) Shunt System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. MIETHKE MedTech Main Business
Table 94. MIETHKE MedTech Latest Developments
Table 95. SOPHYSA Basic Information, Ventriculoperitoneal (VP) Shunt System Manufacturing Base, Sales Area and Its Competitors
Table 96. SOPHYSA Ventriculoperitoneal (VP) Shunt System Product Portfolios and Specifications
Table 97. SOPHYSA Ventriculoperitoneal (VP) Shunt System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. SOPHYSA Main Business
Table 99. SOPHYSA Latest Developments
Table 100. Hpbio Basic Information, Ventriculoperitoneal (VP) Shunt System Manufacturing Base, Sales Area and Its Competitors
Table 101. Hpbio Ventriculoperitoneal (VP) Shunt System Product Portfolios and Specifications
Table 102. Hpbio Ventriculoperitoneal (VP) Shunt System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Hpbio Main Business
Table 104. Hpbio Latest Developments
LIST OF FIGURES
Figure 1. Picture of Ventriculoperitoneal (VP) Shunt System
Figure 2. Ventriculoperitoneal (VP) Shunt System Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ventriculoperitoneal (VP) Shunt System Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Ventriculoperitoneal (VP) Shunt System Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Ventriculoperitoneal (VP) Shunt System Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Ventriculoperitoneal (VP) Shunt System Sales Market Share by Country/Region (2025)
Figure 10. Ventriculoperitoneal (VP) Shunt System Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Adjustable Valve
Figure 12. Product Picture of Monopressure Valve
Figure 13. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Type in 2026
Figure 14. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of One-piece
Figure 16. Product Picture of Two-piece
Figure 17. Product Picture of Other
Figure 18. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Structure in 2026
Figure 19. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Structure (2021-2026)
Figure 20. Ventriculoperitoneal (VP) Shunt System Consumed in Adults
Figure 21. Global Ventriculoperitoneal (VP) Shunt System Market: Adults (2021-2026) & (K Units)
Figure 22. Ventriculoperitoneal (VP) Shunt System Consumed in Children and Newborns
Figure 23. Global Ventriculoperitoneal (VP) Shunt System Market: Children and Newborns (2021-2026) & (K Units)
Figure 24. Global Ventriculoperitoneal (VP) Shunt System Sale Market Share by Application (2025)
Figure 25. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Application in 2026
Figure 26. Ventriculoperitoneal (VP) Shunt System Sales by Company in 2026 (K Units)
Figure 27. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Company in 2026
Figure 28. Ventriculoperitoneal (VP) Shunt System Revenue by Company in 2026 ($ millions)
Figure 29. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Company in 2026
Figure 30. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Geographic Region in 2026
Figure 32. Americas Ventriculoperitoneal (VP) Shunt System Sales 2021-2026 (K Units)
Figure 33. Americas Ventriculoperitoneal (VP) Shunt System Revenue 2021-2026 ($ millions)
Figure 34. APAC Ventriculoperitoneal (VP) Shunt System Sales 2021-2026 (K Units)
Figure 35. APAC Ventriculoperitoneal (VP) Shunt System Revenue 2021-2026 ($ millions)
Figure 36. Europe Ventriculoperitoneal (VP) Shunt System Sales 2021-2026 (K Units)
Figure 37. Europe Ventriculoperitoneal (VP) Shunt System Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Revenue 2021-2026 ($ millions)
Figure 40. Americas Ventriculoperitoneal (VP) Shunt System Sales Market Share by Country in 2026
Figure 41. Americas Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Country (2021-2026)
Figure 42. Americas Ventriculoperitoneal (VP) Shunt System Sales Market Share by Type (2021-2026)
Figure 43. Americas Ventriculoperitoneal (VP) Shunt System Sales Market Share by Application (2021-2026)
Figure 44. United States Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC Ventriculoperitoneal (VP) Shunt System Sales Market Share by Region in 2026
Figure 49. APAC Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Region (2021-2026)
Figure 50. APAC Ventriculoperitoneal (VP) Shunt System Sales Market Share by Type (2021-2026)
Figure 51. APAC Ventriculoperitoneal (VP) Shunt System Sales Market Share by Application (2021-2026)
Figure 52. China Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 56. India Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe Ventriculoperitoneal (VP) Shunt System Sales Market Share by Country in 2026
Figure 60. Europe Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Country (2021-2026)
Figure 61. Europe Ventriculoperitoneal (VP) Shunt System Sales Market Share by Type (2021-2026)
Figure 62. Europe Ventriculoperitoneal (VP) Shunt System Sales Market Share by Application (2021-2026)
Figure 63. Germany Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 64. France Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 65. UK Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales Market Share by Application (2021-2026)
Figure 71. Egypt Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Ventriculoperitoneal (VP) Shunt System in 2026
Figure 77. Manufacturing Process Analysis of Ventriculoperitoneal (VP) Shunt System
Figure 78. Industry Chain Structure of Ventriculoperitoneal (VP) Shunt System
Figure 79. Channels of Distribution
Figure 80. Global Ventriculoperitoneal (VP) Shunt System Sales Market Forecast by Region (2027-2032)
Figure 81. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Ventriculoperitoneal (VP) Shunt System
Figure 2. Ventriculoperitoneal (VP) Shunt System Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ventriculoperitoneal (VP) Shunt System Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Ventriculoperitoneal (VP) Shunt System Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Ventriculoperitoneal (VP) Shunt System Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Ventriculoperitoneal (VP) Shunt System Sales Market Share by Country/Region (2025)
Figure 10. Ventriculoperitoneal (VP) Shunt System Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Adjustable Valve
Figure 12. Product Picture of Monopressure Valve
Figure 13. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Type in 2026
Figure 14. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of One-piece
Figure 16. Product Picture of Two-piece
Figure 17. Product Picture of Other
Figure 18. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Structure in 2026
Figure 19. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Structure (2021-2026)
Figure 20. Ventriculoperitoneal (VP) Shunt System Consumed in Adults
Figure 21. Global Ventriculoperitoneal (VP) Shunt System Market: Adults (2021-2026) & (K Units)
Figure 22. Ventriculoperitoneal (VP) Shunt System Consumed in Children and Newborns
Figure 23. Global Ventriculoperitoneal (VP) Shunt System Market: Children and Newborns (2021-2026) & (K Units)
Figure 24. Global Ventriculoperitoneal (VP) Shunt System Sale Market Share by Application (2025)
Figure 25. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Application in 2026
Figure 26. Ventriculoperitoneal (VP) Shunt System Sales by Company in 2026 (K Units)
Figure 27. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Company in 2026
Figure 28. Ventriculoperitoneal (VP) Shunt System Revenue by Company in 2026 ($ millions)
Figure 29. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Company in 2026
Figure 30. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Geographic Region in 2026
Figure 32. Americas Ventriculoperitoneal (VP) Shunt System Sales 2021-2026 (K Units)
Figure 33. Americas Ventriculoperitoneal (VP) Shunt System Revenue 2021-2026 ($ millions)
Figure 34. APAC Ventriculoperitoneal (VP) Shunt System Sales 2021-2026 (K Units)
Figure 35. APAC Ventriculoperitoneal (VP) Shunt System Revenue 2021-2026 ($ millions)
Figure 36. Europe Ventriculoperitoneal (VP) Shunt System Sales 2021-2026 (K Units)
Figure 37. Europe Ventriculoperitoneal (VP) Shunt System Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Revenue 2021-2026 ($ millions)
Figure 40. Americas Ventriculoperitoneal (VP) Shunt System Sales Market Share by Country in 2026
Figure 41. Americas Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Country (2021-2026)
Figure 42. Americas Ventriculoperitoneal (VP) Shunt System Sales Market Share by Type (2021-2026)
Figure 43. Americas Ventriculoperitoneal (VP) Shunt System Sales Market Share by Application (2021-2026)
Figure 44. United States Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC Ventriculoperitoneal (VP) Shunt System Sales Market Share by Region in 2026
Figure 49. APAC Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Region (2021-2026)
Figure 50. APAC Ventriculoperitoneal (VP) Shunt System Sales Market Share by Type (2021-2026)
Figure 51. APAC Ventriculoperitoneal (VP) Shunt System Sales Market Share by Application (2021-2026)
Figure 52. China Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 56. India Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe Ventriculoperitoneal (VP) Shunt System Sales Market Share by Country in 2026
Figure 60. Europe Ventriculoperitoneal (VP) Shunt System Revenue Market Share by Country (2021-2026)
Figure 61. Europe Ventriculoperitoneal (VP) Shunt System Sales Market Share by Type (2021-2026)
Figure 62. Europe Ventriculoperitoneal (VP) Shunt System Sales Market Share by Application (2021-2026)
Figure 63. Germany Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 64. France Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 65. UK Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa Ventriculoperitoneal (VP) Shunt System Sales Market Share by Application (2021-2026)
Figure 71. Egypt Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries Ventriculoperitoneal (VP) Shunt System Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Ventriculoperitoneal (VP) Shunt System in 2026
Figure 77. Manufacturing Process Analysis of Ventriculoperitoneal (VP) Shunt System
Figure 78. Industry Chain Structure of Ventriculoperitoneal (VP) Shunt System
Figure 79. Channels of Distribution
Figure 80. Global Ventriculoperitoneal (VP) Shunt System Sales Market Forecast by Region (2027-2032)
Figure 81. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global Ventriculoperitoneal (VP) Shunt System Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global Ventriculoperitoneal (VP) Shunt System Revenue Market Share Forecast by Application (2027-2032)
